ResMed Inc (LTS:0KW4)
$ 248.625 -8.5249 (-3.32%) Market Cap: 36.23 Bil Enterprise Value: 36.66 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 96/100

Resmed Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 10:15PM GMT
Release Date Price: $172.16 (+2.89%)
David A. Low
JPMorgan Chase & Co, Research Division - Research Analyst

Hello, everyone. My name is David Low and I cover health care in Australia for JPMorgan. This afternoon, we've got Mick Farrell, CEO of ResMed. Glad to have you, Mick.

Michael J. Farrell
ResMed Inc. - CEO & Chairman

Thanks, David, and thanks, everyone, for joining us. You can read through our disclaimers on our website. And I'm here -- if you're a speed reader, then I'll move through ResMed at a glance. So ResMed is the global leader in respiratory medicine. ResMed stands for respiratory medicine. We're also the global leader in residential care. We make the smallest, the quietest, the most comfortable and most cloud connected and most intelligent therapies on the planet.

We are the global leader in digital health solutions with over 22.5 million 100% cloud-connectable medical devices, selling in over 140 countries worldwide. And we have an asset that's a lot more valuable than our $25 billion market cap, which is 16 billion nights of medical data in the cloud. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot